isoxazoles has been researched along with pleconaril in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Portmann, GA; Simmons, DM | 1 |
| Crump, CE; Hayden, FG; Kaiser, L | 1 |
| Turner, RB | 1 |
| Chase, E; Harris, K; Katpally, U; Reisdorph, N; Siuzdak, G; Smith, TJ; Thomas, JJ | 1 |
| Makarov, VA; Riabova, OB; Schmidtke, M; Wutzler, P; Zieger, R | 1 |
| Aguayo, E; Birkus, G; Cihlar, T; Jordan, R; Lee, G; Mello, C; Rodriguez, M | 1 |
| Lv, W; Wang, Y; Zhang, M; Zhang, Y | 1 |
| Belyaevskaya, SV; Clarke, P; Egorova, A; Ekins, S; Frost, J; Fu, J; Hurst, BL; Kazakova, E; Klose, T; Kuhn, RJ; Lane, TR; Leser, JS; Makarov, V; Riabova, O; Rudy, M; Sherry, B; Tarbet, B; Tyler, KL; Volobueva, AS; Zarubaev, VV | 1 |
1 review(s) available for isoxazoles and pleconaril
| Article | Year |
|---|---|
The treatment of rhinovirus infections: progress and potential.
Topics: 3C Viral Proteases; Antiviral Agents; Clinical Trials as Topic; Combined Modality Therapy; Common Cold; Cysteine Endopeptidases; Dietary Supplements; Drug Therapy, Combination; Echinacea; Enzyme Inhibitors; Histamine H1 Antagonists; Humans; Intercellular Adhesion Molecule-1; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Phytotherapy; Picornaviridae Infections; Plant Extracts; Plants, Medicinal; Pyrrolidinones; Receptors, Virus; Rhinovirus; Valine; Viral Proteins; Zinc | 2001 |
7 other study(ies) available for isoxazoles and pleconaril
| Article | Year |
|---|---|
Microscopic determination of drug solubility in plasma and calculation of injection rates with a plasma circulatory model to prevent precipitation on intravenous injection.
Topics: Androgen Antagonists; Animals; Dogs; Injections, Intravenous; Isoxazoles; Oxadiazoles; Pregnanes; Pyrazoles; Solubility; Tetrazoles | 1995 |
In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.
Topics: Antiviral Agents; Cell Survival; Cells, Cultured; Common Cold; Humans; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Pyrrolidinones; Reverse Transcriptase Polymerase Chain Reaction; Rhinovirus; Spectrophotometry; Valine | 2000 |
Human rhinovirus capsid dynamics is controlled by canyon flexibility.
Topics: Antibodies, Viral; Antigen-Antibody Reactions; Binding Sites; Capsid; HeLa Cells; Humans; Immunoglobulin Fab Fragments; Isoxazoles; Microscopy, Electron; Models, Molecular; Mutation; Oxadiazoles; Oxazoles; Rhinovirus; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Virus Assembly | 2003 |
New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Topics: Antiviral Agents; Drug Design; Drug Resistance, Viral; Enterovirus B, Human; Enterovirus Infections; HeLa Cells; Humans; Isoxazoles; Mutation; Oxadiazoles; Oxazoles | 2009 |
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Topics: Antiviral Agents; Common Cold; Dose-Response Relationship, Drug; HeLa Cells; Humans; In Vitro Techniques; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Piperidines; Pyridazines; Pyrrolidinones; Replicon; Rhinovirus; RNA, Viral; Tubercidin; Valine; Virus Replication | 2014 |
Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Enterovirus; Enterovirus Infections; HeLa Cells; Humans; Isoxazoles; Luminescent Measurements; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Phenylalanine; Pyrrolidinones; Valine; Vero Cells | 2019 |
Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5.
Topics: Animals; Antiviral Agents; Cryoelectron Microscopy; Enterovirus; Enterovirus B, Human; Enterovirus D, Human; Enterovirus Infections; Hand, Foot and Mouth Disease; Isoxazoles; Mice | 2023 |